Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hartnup disease
Comorbidity C0025202|malignant melanoma
Sentences 1
PubMedID- 25687848 There is no standard second-line regimen for malignant melanoma patients with disease progression after first-line chemotherapy, even though progression-free survival (pfs) is short in malignant melanoma.

Page: 1